Between March and December 2020, the incidence of COVID-19 among the BNP-PL cohort was 3.8% (n = 65) and similar in the PAH (4.1%, n= 47) CTEPH (3.2%, n = 18) groups. This evidence concerns the gene NPPB and chronic thromboembolic pulmonary hypertension.